Gene regulation | Long-standing rheumatoid arthritis versus controls | P value | |
---|---|---|---|
Biological processes | |||
Up (cluster 2) | |||
Pheromone response | 0.002 | ||
Chemosensory perception | 0.002 | ||
Pyrimidine metabolism | 0.03 | ||
Down (cluster 1) | |||
Fatty acid beta oxidation | 0.003 | ||
Protein biosynthesisa | 0.007 | ||
Nucleoside, nucleotide, and nucleic acid metabolisma | 0.009 | ||
Constitutive exocytosis | 0.02 | ||
Vitamin biosynthesis | 0.03 | ||
Amino acid transport | 0.04 | ||
Fatty acid metabolism | 0.04 | ||
Molecular functions | |||
Up (cluster 2) | |||
Serine protease | 0.003 | ||
Interleukin receptor | 0.02 | ||
Protease | 0.03 | ||
Nucleotide kinase | 0.04 | ||
Cytokine receptor | 0.04 | ||
Down (cluster 1) | |||
Storage protein | 0.002 | ||
Ribosomal proteina | 0.01 | ||
Metalloprotease inhibitora | 0.02 | ||
Amino acid transporter | 0.02 | ||
Extracellular matrix linker protein | 0.02 | ||
Other receptor | 0.04 | ||
Pathways | |||
Up (cluster 2) | |||
Salvage pyrimidine deoxyribonucleotidesa | 0.003 | ||
Vasopressin synthesis | 0.005 | ||
p38 MAPK pathway | 0.03 | ||
Down (cluster 1) | |||
Vitamin D metabolism and pathway | 0.02 | ||
Histamine receptor-mediated signaling pathway | 0.04 | ||
Enkephalin release | 0.04 |